Researchers evaluated the frequency of severe and nonsevere relapses among patients with giant cell arteritis and assessed the characteristics associated with severe relapse.

These are symptoms of temporal arteritis, which can develop in people with PMR. (Photo credit: E+/Getty Images) Under the new criteria developed by the American College of Rheumatology and the ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Positive findings with color Doppler ultrasound were enough to diagnose giant cell arteritis (GCA) accurately without need ...

For patients with high clinical suspicion of giant cell arteritis (GCA), color Doppler ultrasound of the temporal artery as a first-line diagnostic tool can avoid the need for other diagnostic tests, ...

When something goes wrong with the blood supply, pain is typically a result. Eyebrow pain can be a symptom of giant cell arteritis, which is inflammation of the blood vessels in the neck, face, and ...

Data taken from [36]. Polymyalgia rheumatica (PMR) is the second most common autoimmune rheumatic disorder; giant cell arteritis (GCA) is the most frequent vasculitis in the elderly. PMR patients ...

AbbVie disclosed positive top-line results from a study on upadacitinib to treat adults with giant cell arteritis, an autoimmune disease. The drugmaker said its Phase 3 study showed upadacitinib ...

For informational purposes only. Consult a medical professional for advice. Source: Focus Medica. Inflammation of the blood vessels that damages the aorta, the large artery of the heart, and its ...

ANSWER: Transient loss of vision in one eye is called “amaurosis fugax” and is often considered a TIA, which is a big warning sign of an impending stroke. You are wise to take it seriously. Many ...

Giant cell arteritis, also known as temporal arteritis, is an autoimmune disease that causes inflammation of the temporal and other cranial arteries, the aorta, and other large and medium arteries.

A history of pregnancy complications can put women with autoimmune disease at a higher risk for CVD. Prophylaxis during ...

The phase 3 SELECT-GCA study evaluated the efficacy and safety of upadacitinib in patients 50 years of age and older with GCA.